Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review

References

• Takai K, Nikkuni K, Shibuya H, et al. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki. 2010;51(5):320–325.
   PubMedGoogle Scholar
• Masaki Y, Kawabata H, Takai K, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103(6):686–692.
   PubMed Web of Science ®Google Scholar
• Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016;91(2):220–226.
   PubMed Web of Science ®Google Scholar
• Noda-Narita S, Sumida K, Sekine A, et al. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report. CEN Case Rep. 2018;7(1):162–168.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Tsujimoto H, Yamamoto K, et al. Clinicopathological features of progressive renal involvement in TAFRO syndrome: a case report and literature review. Medicine (Baltimore). 2017;96(40):e8216.
   Web of Science ®Google Scholar
• Shirai T, Onishi A, Waki D, et al. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Medicine (Baltimore). 2018;97(23):e11045.
   Web of Science ®Google Scholar
• Ben-Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol. 1994;91(1):1–6.
   Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Kawabata H, Kurose N, et al. Sjogren’s syndrome manifesting as clinicopathological features of TAFRO syndrome: a case report. Medicine. 2017;96(50):e9220.
   Web of Science ®Google Scholar
• Nara M, Komatsuda A, Itoh F, et al. Two cases of thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly (TAFRO) syndrome with high serum procalcitonin levels, including the first case complicated with adrenal hemorrhaging. Intern Med. 2017;56(10):1247–1252.
   Web of Science ®Google Scholar
• Kawashima M, Usui T, Okada H, et al. TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol. 2017;27(6):1093–1097.
   PubMed Web of Science ®Google Scholar
• Ito S, Uchida T, Itai H, et al. Serial manifestation of acute kidney injury and nephrotic syndrome in a patient with TAFRO syndrome. Intern Med. 2018;57(21):3129–3133.
   Web of Science ®Google Scholar
• Shimada Y, Adachi M, Kobayashi N, et al. A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones. Clin Case Rep. 2018;6(4):638–643.
   Web of Science ®Google Scholar
• Nakamori A, Akagaki F, Yamaguchi Y, et al. Nephrotic syndrome with thrombocytopenia, lymphadenopathy, systemic inflammation, and splenomegaly. Intern Med. 2018;57(8):1123–1129.
   Web of Science ®Google Scholar
• Morel G, Mootien J, Guiot P, et al. Anasarca, fever, thrombocytopenia, organomegaly, and multiorgan failure in a 24-year-old pregnant woman. Case Rep Crit Care. 2017;2017:3871593.
   Google Scholar
• Ozawa Y, Yamamoto H, Yasuo M, et al. Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography. Respir Investig. 2017;55(2):176–180.
   Web of Science ®Google Scholar
• Nakamura G, Homma N, Kasai A, et al. Magnetic resonance imaging of bone marrow for TAFRO syndrome. Modern Rheumatol. 2016;29(3)551–557.
   Google Scholar
• Takayama Y, Kubota T, Ogino Y, et al. TAFRO syndrome with disseminated intravascular coagulation successfully treated with tocilizumab and recombinant thrombomodulin. Intern Med. 2018;57(9):1291–1296.
   Web of Science ®Google Scholar
• Igawa T, Sato Y. TAFRO syndrome. Hematol Oncol Clin North Am. 2018;32(1):107–118.
   PubMed Web of Science ®Google Scholar
• Okumura M, Ujiro A, Otsuka Y, et al. Cardiac arrest caused by rapidly increasing ascites in a patient with TAFRO syndrome: a case report. Acute Med Surg. 2017;4(3):344–348.
   Web of Science ®Google Scholar
• Takasawa N, Sekiguchi Y, Takahashi T, et al. A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol. 2016;29(1):198–202.
   Google Scholar
• Yamaga Y, Tokuyama K, Kato T, et al. Successful treatment with cyclosporin A in tocilizumab-resistant TAFRO syndrome. Intern Med. 2016;55(2):185–190.
   Web of Science ®Google Scholar
• Konishi Y, Takahashi S, Nishi K, et al. Successful treatment of TAFRO syndrome, a variant of multicentric Castleman’s disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2. Tohoku J Exp Med. 2015;236(4):289–295.
   PubMed Web of Science ®Google Scholar
• Allegra A, Rotondo F, Russo S, et al. Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis. 2015;55(3):206–207.
   PubMed Web of Science ®Google Scholar
• Inoue M, Ankou M, Hua J, et al. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report. J Clin Exp Hematopathol. 2013;53(1):95–99.
   PubMedGoogle Scholar
• Mizuno H, Sekine A, Oguro M, et al. Renal histology in a patient with TAFRO syndrome: a case report. Hum Pathol. 2018;82:258–263.
   Web of Science ®Google Scholar
• Nakamura Y, Iwamoto K, Fujisawa Y, et al. Multiple haemangiomas in TAFRO syndrome with atypical features of glomeruloid and epithelioid haemangiomas. Eur J Dermatol. 2018;28:371–372.
   Web of Science ®Google Scholar
• Masaki Y, Nakajima A, Iwao H, et al. Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia – a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop. 2013;53:79–85.
   PubMedGoogle Scholar
• Ohya E, Mizutani M, Sakaguchi H, et al. Diffuse large B-cell lymphoma during corticosteroid therapy for TAFRO syndrome. Intern Med. 2016;55(19):2861–2867.
   Web of Science ®Google Scholar
• Hiramatsu S, Ohmura K, Tsuji H, et al. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(1):64–71.
   Google Scholar
• Takai K, Nikkuni K, Momoi A, et al. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematopathol. 2013;53(1):63–68.
   PubMedGoogle Scholar
• Awano N, Inomata M, Sonoda Y, et al. A case of multicentric Castleman’s disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy. J Clin Exp Hematopathol. 2013;53(1):101–105.
   PubMedGoogle Scholar
• Noda Y, Saka Y, Kato A, et al. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage. Clin Nephrol Case Stud. 2018;6(1):16–20.
   Google Scholar
• Fujiwara S, Mochinaga H, Nakata H, et al. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Int J Hematol. 2016;103(6):718–723.
   Web of Science ®Google Scholar
• Nagayama Y, Yamano M, Yagame M, et al. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review. BMC Nephrol. 2019;20(1):375.
   Web of Science ®Google Scholar
• Meguri Y, Asada N, Nakasako Y, et al. A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange. Ann Hematol. 2019;98(2):537–539.
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Ito K, Takamura A, et al. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. J Med Case Rep. 2018;12(1):295.
   Google Scholar
• Oka S, Ono K, Nohgawa M. Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements. Clin Case Rep. 2018;6(4):644–650.
   Web of Science ®Google Scholar
• Louis C, Vijgen S, Samii K, et al. TAFRO syndrome in Caucasians: a case report and review of the literature. Front Med. 2017;4:149.
   Web of Science ®Google Scholar